Original ArticleNew Diagnostic Criteria for Fibromyalgia: Here to Stay?Nuevos criterios diagnósticos de fibromialgia: ¿vinieron para quedarse?☆
Introduction
Fibromyalgia (FM) is a syndrome characterized by diffuse, chronic musculoskeletal pain, non-articular in origin, which is evidenced by palpation of tender points in specific anatomic areas and is usually accompanied by unrefreshing sleep, fatigue, morning stiffness and cognitive impairment. Fibromyalgia affects about 0.5%–5% of the population and is characterized by ambiguity in the diagnosis, uncertainty in the understanding of its pathophysiology and the difficulties of physicians to address it globally.1
In 1990, the American College of Rheumatology (ACR) published classification criteria, based on an examination of tender points, requiring specialized evaluation.2 The presence of chronic widespread (more than 3 months), generalized pain (in at least 3 of the 4 body quadrants), with 11 or more of 18 specific tender points was evaluated.
The impression that the FM was exclusively a musculo-skeletal disease was erroneously created. With the passage of time, there appeared a number of objections (practical and philosophical) to the 1990 ACR classification criteria. It first became increasingly evident that the tender point count was a barrier and was rarely performed in primary care, where most cases of FM were diagnosed, and when they did, these were often evaluated incorrectly. Many physicians were unaware of how to perform the examination of tender points, or simply omitted the procedure. Thus, in practice, the diagnosis of FM has been based primarily on the symptoms reported by patients.
Second, although the symptoms of fibromyalgia (fatigue, unrefreshing sleep, cognitive, etc.) were not considered by the ACR 1990, they have lately been recognized as having hierarchical importance. FM, then, is no longer considered a peripheral musculoskeletal disease and there has been a growing recognition of central sensitization of pain as the underlying neurobiological basis, which explains most of the systemic symptoms.
The new FM diagnostic criteria proposed in 2010 consist of a widespread pain index (Widespread Pain Index [WPI]) and a Symptom Severity Score [SS-Score]. According to the literature, this new method correctly classified 88.1% of cases diagnosed by the 1990 ACR criteria and, since it is essentially based on the information provided by patients, requires no physical examination nor requires specialized observer training, and is well suited to the field of Primary Health Care.3
On the other hand, the heterogeneity of the disease implies that not all patients with FM present and evolve in the same way; For these reasons, Giesecke et al. have issued a recommendation to classify FM into 3 groups, those associated with depression, those where there is an important functional or somatoform disorder or do not have psychopathology. This classification enables the homogenization of groups of patients with similar characteristics and potential common therapeutic approaches.4, 5
The primary objective of this study was to evaluate the degree of agreement between the old criteria for FM and the 2010 ACR criteria.
Secondary objectives were to assess whether there is a correlation between points and painful areas, and signs and symptoms that predict a specific type of FM (depressive, hyperalgesic or somatizing) and, secondly, to identify the signs and symptoms that exhibit a greater correlation with vital disease involvement, the impact of the disease for different types according to each criterion.
Section snippets
Materials and Methods
We present a cross-sectional comparative study, approved by the Clinical Research Ethics Committee of the Chiron Dexeus University Hospital of Barcelona, Spain.
The study included patients with a clinical diagnosis of FM, 18 or older, who came successively to the outpatient Rheumatology Clinic of the Valld’Hebron Hospital and the Chiron Dexeus University Hospital in Barcelona between 15 August 2012 and 15 November 2012, and provided informed consent for participation in the study. The data was
Results
The study included 206 patients; 130 were seen at the Rheumatology Department of the Valld’Hebron Hospital and 76 at the Chiron Dexeus University Hospital in Barcelona (Spain). The mean age ± SD of the patients was 53.71 ± 9.48 years. The youngest patient was 30 years and the oldest 82 (Table 1). 95.1% of FM patients analyzed were female. The mean time since disease onset was approximately 8 ± 5.84 years. At the time of the visit, 89.8% of patients met the previous criteria for the diagnosis of FM.
Discussion
In our study, the demographic characteristics of the sample did not differ from the large published series.4, 11
The largest subgroup of patients belonged to the somatizing type, which has been identified as having the worst prognosis for presenting high levels of anxiety, depression, catastrophizing and hyperalgesia, and a low control over pain; in other studies, the predominant type was depressive FM, which represents about half of the cases 5.
Most patients who met the criteriaACR 2010 for FM
Protection of people and animals
The authors declare this research did not perform experiments on humans or animals.
Data confidentiality
The authors declare that they have followed the protocols of their workplace on the publication of data from patients and all patients included in the study have received sufficient information and gave written informed consent to participate in the study.
Right to privacy and informed consent
The authors have obtained the informed consent of patients and/or subjects referred to in the article. This document is in the possession of the corresponding
Conflict of Interest
No financial, work-related or personal conflict of interest was disclosed.
Acknowledgement
Our sincere thanks to the patients who agreed to participate in this study.
References (16)
- et al.
Propuesta de una versión de consenso del Fibromyalgia Impact Questionnaire (FIQ) para la población española
Reumatol Clin
(2007) - et al.
Validación de la versión española de la escala de la catastrofización ante el dolor (Pain Catastrophizing Scale) en la fibromialgia
Med Clin (Barc)
(2008) - et al.
New and modified fibromyalgia diagnostic criteria: ambiguity, uncertainty, and difficulties complicate diagnosis and management
J Musculoskel Med
(2012) - et al.
The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicente rcriteria committee
Arthritis Rheum
(1990) - et al.
The American College of Rheumatology Preliminary Diagnostic Criteria for fibromyalgia and measurement of symptom severity
Arthritis Care Res
(2010) - et al.
Subtipos de pacientes con fibromialgia, características psicopatológicas y calidad de vida
Actas Esp Psiquiatr
(2011) - et al.
Documento de consenso interdisciplinar para el tratamiento de la fibromialgia
Actas Esp Psiquiatr
(2010) - et al.
Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors
Arthritis Rheum
(2003)
Cited by (0)
- ☆
Please cite this article as: Moyano S, Kilstein JG, Alegre de Miguel C. Nuevos criterios diagnósticos de fibromialgia: ¿vinieron para quedarse? Reumatol Clin. 2015;11:210–214.